Viewing Study NCT01440361


Ignite Creation Date: 2025-12-24 @ 12:14 PM
Ignite Modification Date: 2025-12-29 @ 2:07 PM
Study NCT ID: NCT01440361
Status: WITHDRAWN
Last Update Posted: 2014-07-28
First Post: 2011-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 114870
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators